Introduction
You're comparing companies by valuation and want a cleaner operating multiple, not a metric messy with leverage, dividends, or one-off gains-so look at EV/NOPAT. EV/NOPAT links total firm value (enterprise value) to after-tax operating profit (NOPAT), where NOPAT ≈ EBIT × (1 - tax rate); for US fiscal 2025 use the federal rate of 21% when estimating NOPAT. One-liner: EV/NOPAT shows how many years of operating profit buyers pay for the whole firm. Here's the quick math: if EV = $1,000,000,000 and NOPAT = $100,000,000, EV/NOPAT = 10x-buyers pay ten years of operating profit, which is a defintely cleaner comparitor across firms.
Key Takeaways
- EV/NOPAT = Enterprise Value ÷ NOPAT; it shows how many years of after‑tax operating profit buyers pay (NOPAT ≈ EBIT × (1-tax)); for US FY2025, use federal tax = 21% as a baseline.
- Enterprise Value = market cap + gross debt + preferred + minority interest - cash/short‑term investments; use market cap at FY2025 close and FY2025 balance‑sheet debt for consistency.
- NOPAT should use FY2025 operating income (EBIT) adjusted for the effective tax rate and exclude non‑operating items, one‑offs, financing gains/losses; adjust for operating leases and capitalized R&D as needed.
- Stepwise: gather FY2025 market cap, debt, cash → compute EV; extract FY2025 EBIT and apply tax → compute NOPAT; divide EV by NOPAT and disclose whether numerator/denominator are FY2025 or TTM; run sensitivity on tax and net debt.
- Interpret carefully: compare peers in the same industry/capital intensity (lower = cheaper), translate to implied payback years, and supplement with EV/EBITDA, ROIC and adjustments for off‑balance‑sheet items or cyclicality.
What EV (Enterprise Value) is
EV equals market capitalization plus net debt plus preferred stock and minority interest
You're comparing firms and need one clean line: enterprise value (EV) represents the total price to buy the whole operating business, not just the equity. EV = market capitalization + net debt + preferred stock + minority (noncontrolling) interest.
Here's the quick math you should run every time. Get market cap from the share price times fully diluted shares (use diluted shares if you want option dilution included). Pull preferred and minority interest from the FY2025 balance sheet - they sit in the liabilities/equity section. Add them to the capital you'd pay the equity holders.
One-liner: EV sums what every stakeholder would need to be paid to own the firm outright.
- Use diluted shares for consistency
- Include convertible debt only if dilutive (or run both adjusted and unadjusted EV)
- Record preferred stock at liquidation value if disclosed
Subtract cash and short-term investments from gross debt to get net debt
Net debt = gross interest-bearing debt - cash and short-term investments. Gross debt typically equals short-term borrowings + current portion of long-term debt + long-term debt (and sometimes commercial paper). Cash and equivalents include bank deposits and money-market placements shown as cash and short-term investments on the FY2025 balance sheet.
Steps to be precise:
- Extract gross debt from FY2025 liabilities line items on the consolidated balance sheet
- Take cash + ST investments from the same FY2025 balance sheet; exclude restricted cash only if clearly labeled and not usable
- Compute net debt and flag any large, illiquid securities - don't treat illiquid marketable securities as cash
- Document the date for each item; mismatch increases error
Example (FY2025 illustrative): gross debt $12.5 billion, cash & short-term investments $3.1 billion → net debt = $9.4 billion. What this estimate hides: off-balance-sheet leases or repo lines can materially change the net debt picture, so check notes.
One-liner: Net debt converts gross borrowings into the realistic cash you must fund on an acquisition.
Use market cap at FY2025 close and debt per balance sheet date for consistency
Align timing: take market capitalization as of the FY2025 close (use the company's fiscal year-end date) and use debt, cash, preferred, and minority from that same FY2025 balance sheet. Mismatched dates produce distortions - for example, market cap can move 20%+ after a major quarter or guidance change.
Currency and consolidation guidance:
- Convert all items to a single reporting currency using the spot FX rate on the market-cap date (or disclose the average if you choose average market cap)
- Prefer consolidated financial statements - parent-only reporting omits subsidiaries and skews EV
- For ADRs or dual listings, use the primary listing market cap or show both; reconsolidate shares outstanding to the same share class definition
- When debt is in different currencies, show each tranche and FX-adjusted totals; call out material hedges
Best practice: create a one-line EV reconciliation table dated FY2025 close with source footnotes (share price source, balance sheet date, FX rates). If FY2025 reporting lag or restatements exist, use TTM and label it clearly - defintely disclose.
One-liner: Match dates and currency so EV compares apples to apples across peers.
Calculating NOPAT (Net Operating Profit After Tax)
You're comparing companies by valuation and want a cleaner operating profit measure that aligns with enterprise value. Direct takeaway: NOPAT = EBIT × (1 - effective tax rate), and you should use FY2025 operating results so the numerator matches EV timing. One-liner: NOPAT is the firm's after-tax operating profit available to all capital providers.
Formula and timing
Start with reported operating income (EBIT) from the FY2025 income statement, not pretax income or net income. Compute an FY2025 effective tax rate (ETR) from FY2025 tax expense divided by FY2025 pretax income, after stripping financing and one-offs. Then apply the formula: NOPAT = EBIT × (1 - ETR).
Steps to follow:
- Pull FY2025 EBIT from consolidated financials
- Compute FY2025 ETR = FY2025 tax expense / FY2025 pretax income
- Apply NOPAT formula using FY2025 figures
Quick math example: if FY2025 EBIT = $1,200 million and FY2025 ETR = 18%, then NOPAT = $1,200m × (1 - 0.18) = $984 million. What this estimate hides: deferred tax timing, state taxes, and nonrecurring tax credits-restate ETR if those items materially distort FY2025.
Exclude non‑operating items, one‑offs, and financing gains/losses
EBIT can include items that are not part of ongoing operations. You must remove those before applying the tax rate so NOPAT reflects sustainable operating profit. Typical items to strip: gains/losses on asset sales, restructuring charges flagged as one‑off, investment income or losses, and forex trading gains tied to financing, not operations.
Practical checklist:
- Reconcile EBIT to the note disclosure for one-offs
- Subtract non‑operating gains from reported EBIT
- Add back non‑operating losses to reported EBIT
- Tax‑adjust each adjustment by multiplying by (1 - ETR)
Example: reported FY2025 EBIT = $1,200m, FY2025 one‑time gain on disposal = $150m. Adjusted EBIT = $1,050m; with ETR 18%, adjusted NOPAT = $1,050m × 0.82 = $861 million. Defintely note each adjustment line and source footnote.
Adjust for operating leases and capitalized R&D where needed
Accounting choices change the face of EBIT. Address two common comparability issues: operating leases and capitalized R&D. The goal is consistency across peers so NOPAT measures like‑for‑like operating profit.
Operating leases:
- If FY2025 reporting uses IFRS16/ASC842, leases already hit EBIT as depreciation-no addback needed
- If operating lease expense sits below EBIT, add that FY2025 lease expense back to EBIT to reflect capitalized treatment
- Tax‑effect the lease addback: NOPAT adjustment = lease addback × (1 - ETR)
Capitalized R&D:
- Find FY2025 R&D expensed, capitalized additions, and amortization in the notes
- Choose a policy: expense all R&D or capitalize consistently across peers
- If you expense R&D for comparability, add back FY2025 R&D amortization and subtract a normalized annual R&D expense equal to capitalized additions amortized over a reasonable useful life
Example mix: FY2025 operating lease expense outside EBIT = $80m; ETR = 18%. NOPAT rises by $80m × 0.82 = $65.6 million when you move leases into operating profit. For R&D: FY2025 capitalized additions = $300m, amortization = $60m; decide on useful life (say 5 years) and adjust EBIT and NOPAT accordingly-document assumptions and stress test useful life +/- 2 years.
Calculating EV/NOPAT
You're comparing companies by valuation and want a cleaner operating multiple; below are concrete, FY2025-aligned steps to build enterprise value (EV), compute net operating profit after tax (NOPAT), and get the EV/NOPAT ratio you can act on.
Assembling enterprise value inputs
One-liner: EV = how the market values the whole firm, including debt and minority claims, less cash.
Step: pull the market capitalization at the company's FY2025 close (share price at the fiscal year-end date × fully diluted shares outstanding). Use the company's FY2025 balance sheet date to collect gross debt (short-term + long-term), preferred stock, and minority interest.
Best practices and checks:
- Convert foreign currency amounts to USD using the FY2025 year-end FX rate.
- Use consolidated financials unless you have a clear reason to use parent-only reporting.
- Compute net debt as gross debt minus cash and short-term investments; don't double-count restricted cash.
- Include off-balance-sheet operating lease obligations and material pension deficits as additions to EV when they affect long-term claims on cash flow.
What to watch: mismatched timing (market cap at FY2025 close vs debt at a different date), trust the balance sheet date for debt, and reconfirm any post-close debt issuances or large buybacks - defintely disclose those adjustments.
Deriving NOPAT from operating results
One-liner: NOPAT converts operating profit into the cash profit available to all capital providers after tax, excluding financing effects.
Step: take FY2025 operating income (EBIT) from the income statement and apply the FY2025 effective tax rate: NOPAT = EBIT × (1 - t). Prefer the company's reported effective tax rate for FY2025 (income tax expense / pre-tax income) but test a statutory or normalized rate if the reported rate is distorted by one-offs.
Adjustments and rules of thumb:
- Exclude non-operating items, gains/losses, and financing income from EBIT before applying tax.
- Capitalized R&D: add back the amortized incremental operating profit if you choose to capitalize R&D for comparability.
- Operating lease expense: convert to the finance-lease equivalent (add right-of-use asset amortization and interest back into EBIT adjustments) so leases match the EV adjustments.
- Use FY2025 results to match EV timing; if FY2025 is restated or lagged, prefer a TTM (trailing twelve months) NOPAT with a clear note.
What this estimate hides: effective tax rate volatility, deferred tax timing, and large non-recurring items can swing NOPAT materially-flag them.
Computing the ratio and quick math example
One-liner: EV/NOPAT ≈ how many years of after-tax operating profit a buyer is paying for the whole firm.
Step: EV divided by NOPAT. State whether NOPAT is FY2025 or TTM; for strict alignment use FY2025 values for both EV and NOPAT.
Quick math example (FY2025-aligned illustrative numbers):
- Market cap at FY2025 close: $50,000,000,000
- FY2025 gross debt: $10,000,000,000
- Preferred stock: $0
- Minority interest: $500,000,000
- Cash and short-term investments: $5,000,000,000
- FY2025 EBIT: $4,000,000,000
- FY2025 effective tax rate (t): 21%
Here's the quick math: EV = 50B + 10B + 0 + 0.5B - 5B = $55,500,000,000. NOPAT = 4B × (1 - 0.21) = $3,160,000,000. EV/NOPAT = 55.5B / 3.16B ≈ 17.6 years.
Sensitivity checks (practical): vary the tax rate by ±200 basis points and net debt by ±$1B to see the range; for example, if t = 19% NOPAT = 3.24B and EV/NOPAT ≈ 17.1; if net debt +$1B EV = 56.5B and EV/NOPAT ≈ 17.9. What this hides: margins, capex needs, and growth expectations-run a simple ROIC check alongside EV/NOPAT.
Next step and owner: Finance - collect FY2025 market cap, gross debt, cash, FY2025 EBIT and effective tax rate; compute EV, NOPAT, EV/NOPAT, and publish a sensitivity table by Friday.
Interpreting and using EV/NOPAT
Lower versus higher multiples
You want to know quickly if a company looks cheap on operating profit-EV/NOPAT does that: a lower multiple means buyers pay fewer years of operating profit, a higher multiple means they pay more.
One-liner: Lower EV/NOPAT ≈ cheaper on operating earnings; higher ≈ premium.
Practical steps
- Calculate EV at FY2025 close and NOPAT for FY2025 (or TTM aligned to that date).
- Compute EV/NOPAT and compare to a small peer set (3-5 firms) in the same industry.
- Flag outliers: more than +50% vs peer median needs a driver (growth, ROIC, scarcity).
Best practices and considerations
- Prefer FY2025 alignment-use market cap at FY2025 close and FY2025 balance-sheet items.
- When NOPAT is negative, the multiple is meaningless; focus on operational fixes or cash-burn runway instead.
- Account for one-offs: remove non-operating gains/losses from EBIT before tax adjustment.
Here's the quick math: if EV = $12.0bn and NOPAT = $600m, EV/NOPAT = 20x.
What this estimate hides: growth expectations and capital intensity-two companies at 20x can be very different if one grows NOPAT 20% annually and the other is flat.
Industry and capital-intensity comparability
You should only compare EV/NOPAT within the same industry and similar asset structures-capital-light software versus capital-heavy utilities will give misleading differences.
One-liner: Compare apples to apples-industry and capital intensity matter most.
Practical steps
- Group peers by NAICS/SIC and by capital intensity (fixed assets to sales or capital expenditures as % of sales in FY2025).
- Normalize for leases and pensions: add present value of operating leases and pension deficits to EV if material.
- Adjust NOPAT if a company capitalizes R&D (treat as investment) or expensed it-restate FY2025 NOPAT for consistency.
Best practices and considerations
- Use ROIC (return on invested capital) alongside EV/NOPAT to see if high multiple buys high returns; a high EV/NOPAT with ROIC > WACC can be justified.
- For cyclical industries, use a 3-5 year average NOPAT centered on FY2025 to avoid peak/trough distortion.
- Check currency exposures and consolidated vs parent-only reporting-convert all peer data to the same reporting basis for FY2025.
Example: two firms with EV/NOPAT = 10x-if Firm A has FY2025 CapEx/Sales = 2% and ROIC = 18%, it's a different risk profile than Firm B with CapEx/Sales = 12% and ROIC = 8%.
Implied payback and complementary metrics
Translate EV/NOPAT into years to recoup operating profit: EV/NOPAT ≈ payback years (ignoring growth and reinvestment)-that gives an intuitive sense of price.
One-liner: EV/NOPAT tells you roughly how many years of FY2025 operating profit you pay for the firm.
Practical steps
- Compute payback years = EV / NOPAT. If EV = $8.5bn and NOPAT = $850m, payback = 10 years.
- Run sensitivity tables: vary tax rate ±200 bps and net debt ±10% to see multiple movement.
- Cross-check with EV/EBITDA and ROIC: if EV/NOPAT is low but ROIC < WACC, low multiple reflects poor capital returns not a bargain.
Best practices and considerations
- Use EV/EBITDA to assess cash-generation before capital charges; use EV/NOPAT to capture after-tax operating returns; use ROIC to test efficiency of invested capital.
- For growing companies, convert EV/NOPAT payback into a DCF sanity check: does implied growth required to justify the multiple match management guidance?
- Document assumptions clearly: state FY2025 source dates, tax-rate used, and any adjustments; defintely disclose if you used TTM instead of fiscal year due to reporting lag.
Next step: Finance-produce an FY2025-aligned table for target and 3-5 peers showing EV, NOPAT, EV/NOPAT, ROIC, and a sensitivity +/- tax and net debt by Friday.
Calculating EV/NOPAT - Common adjustments, risks, and comparability fixes
You're trying to compare EV/NOPAT across companies but face cycles, off-balance items, and accounting quirks; fix these first so the multiple means the same thing for every firm. The quick takeaway: normalize NOPAT across cycles, add genuine economic liabilities to EV, recast operating profit for accounting differences, and run sensitivities on tax and net debt.
Normalize cyclical NOPAT and handle reporting lag
Situation: cyclical companies or delayed FY2025 filings distort a one-year NOPAT; you need a representative operating profit number before dividing EV by NOPAT. Start with the simple rule: prefer a cycle-average NOPAT or TTM (trailing twelve months) aligned to EV timing.
Steps to follow:
- Collect FY2025 NOPAT and the prior 4 years of NOPAT (or TTM if FY2025 missing).
- Compute a cycle average (median if outliers exist) across the last 3-5 years; call this NOPATavg.
- If FY2025 is an outlier due to one-offs, weight NOPATavg 70/30 toward the cycle average vs FY2025 to reflect current operations.
- If FY2025 reporting lags or restatements occur, use TTM ending in the most recent month with audited data and clearly note the period; defintely disclose adjustments.
One-liner: use a 3-5-year average or a TTM aligned to EV to avoid buying cyclicality as growth.
What to watch: don't mix FY2025 NOPAT with an EV computed at a different close date without footnoting; state the exact periods used (for example, EV at FY2025 close and NOPAT as FY2025 average or TTM to that same close).
Owner: Financial reporting-publish the NOPATavg and the period used, with the raw yearly NOPATs, by close of quarter.
Adjust enterprise value for off-balance-sheet items and contingent liabilities
Situation: reported EV omits economic claims like operating leases, pension deficits, and major guarantees; that underestimates the real price a buyer pays. Treat EV as economic net claim on assets, not just accounting debt.
Practical steps:
- Add lease liabilities under IFRS 16/ASC 842: take reported lease liabilities or capitalize remaining rent and discount at the company's pre-tax cost of debt; add that to gross debt.
- Add funded pension deficits: if pension plan is underfunded by $X, add the shortfall to net debt; if overfunded, reduce net debt accordingly.
- Add guarantees and contingent liabilities that are probable and reasonably estimable; use management disclosures to estimate a present value and add to EV.
- Subtract excess cash not needed for operations (e.g., >12 months of working capital) from gross cash before computing net debt.
One-liner: convert all meaningful off-balance claims into an EV adjustment so you compare apples to apples.
Quick math guidance: if reported gross debt is $1.2B, lease liability PV is $300M, and pension deficit is $150M, add $450M to gross debt before subtracting cash to get adjusted EV.
Owner: Modeling-produce an adjusted EV bridge (reported EV → adjusted EV) and a sensitivity that adds/removes each off-balance item.
Recast NOPAT for accounting differences and run sensitivity analysis
Situation: companies report operating profit differently-capitalized R&D, one-offs, and financing gains distort true operating earnings. You must recast EBIT into a comparable NOPAT.
Concrete recast steps:
- Start with FY2025 EBIT (operating income). Remove non-operating gains/losses and recurring unusual items (e.g., asset sale gains).
- Add back amortization from capitalized R&D if management capitalizes development costs; treat the capitalized amount as an operating expense and add a notional amortization to EBIT.
- If R&D is historically capitalized, compute an annualized amortization (e.g., capitalized R&D balance ÷ useful life) and add it to EBIT.
- Apply the effective tax rate for FY2025 to compute NOPAT = EBIT_recast × (1 - tax rate); document how you derived the effective tax rate (statutory vs cash vs recurring).
- Run sensitivity tables: vary the effective tax rate by ±200 basis points and net debt adjustments by ±10-30% to see EV/NOPAT movement.
One-liner: recast operating profit to include economically recurring operating expenses, then stress-test EV/NOPAT across tax and net-debt swings.
Example sensitivity: with adjusted EBIT of $400M and base tax 20%, NOPAT = $320M. If tax rises to 22%, NOPAT falls to $312M, and EV/NOPAT moves accordingly - show the table.
Limits and notes: capitalized R&D useful lives and lease discount rates are judgment calls-document assumptions, run +/- scenarios, and label the primary case clearly.
Owner: Modeling-deliver a sensitivity workbook (tax, net debt, lease PV, R&D capitalization) and a clear primary-case EV/NOPAT by the next valuation cycle.
Calculating EV/NOPAT
Action: collect FY2025 market cap, debt, cash, FY2025 EBIT, and effective tax rate
Takeaway: collect consistent FY2025 items-market cap at the company fiscal-year close, gross debt, cash & short-term investments, FY2025 EBIT, and the FY2025 effective tax rate so EV and NOPAT align exactly.
Steps to follow:
- Pull market cap using the closing share price on the company's FY2025 fiscal year-end date and multiply by diluted share count from the FY2025 filing.
- Grab gross debt, preferred stock, and minority interest from the FY2025 balance sheet (use consolidated statements); list debt maturities and interest type.
- Record cash and short-term investments from FY2025 balance sheet to compute net debt = gross debt - cash & short-term investments.
- Extract FY2025 operating income (EBIT) from the income statement, then capture the company-reported FY2025 effective tax rate (tax expense ÷ pre-tax earnings or disclosed rate).
- Document currency for each item and convert to a single reporting currency (USD) using the fiscal year-end FX rate; note any parent-only vs consolidated reporting differences.
Best practices and checks:
- Use primary sources: FY2025 10-K/20-F or audited annual report; supplement with exchange close prices and a trusted market data provider.
- Reconcile market cap = price × diluted shares; flag large stock-based dilution or recent secondary offerings.
- Flag off-balance-sheet items (operating leases under old accounting, pension deficits) for later adjustment; note these in a data column.
- Timestamp each data point and capture the source URL or filing page for audit trail.
One-liner: get the FY2025 closing market price, balance-sheet debt/cash, FY2025 EBIT, and the FY2025 effective tax rate into a single vetted spreadsheet-defintely capture sources.
Owner: Finance-compute EV and NOPAT and publish EV/NOPAT and sensitivity table
Takeaway: Finance computes EV = market cap + gross debt + preferred + minority - cash, then NOPAT = EBIT × (1 - effective tax rate), and publishes the ratio plus sensitivities.
Concrete steps:
- Compute EV using FY2025 market cap and FY2025 balance-sheet items; show intermediate lines for gross debt, cash, preferred, minority, and resulting net debt.
- Calculate NOPAT = FY2025 EBIT × (1 - FY2025 effective tax rate). Exclude one-offs and non-operating items-document every adjustment.
- Build a one-row formula for each company: EV / [EBIT × (1 - t)] and label whether EBIT is FY2025 or TTM.
- Create a sensitivity table: vary tax rate by ±200 bps, net debt by ±10%, and one-off adjustments by ±5-10%; show resulting EV/NOPAT ranges.
Output and governance:
- Publish an Excel/CSV with columns: company, FY2025 market cap (USD), gross debt, cash, net debt, EBIT (FY2025), effective tax rate, NOPAT, EV, EV/NOPAT, adjustment notes, source links.
- Attach a one-page memo listing major judgment calls (treatment of leases, capitalized R&D, extraordinary items) and who approved them.
- Keep the workbook versioned and stored in the finance shared drive with access controls.
One-liner: Finance: compute EV and NOPAT, build sensitivity table, and publish a source-tagged workbook.
Owner and timing: Finance to deliver the initial EV/NOPAT table and sensitivity sheet within 5 business days from data collection completion.
Next step: benchmark against 3-5 peers in same industry using FY2025-aligned data
Takeaway: compare EV/NOPAT within a tight peer set of 3-5 firms with matched FY2025 data and consistent adjustments to surface relative value and outliers.
How to pick peers and prepare the benchmark:
- Choose peers by product line, geography, and capital intensity-prefer companies within the same NAICS/industry classification and within ~2x revenue scale.
- Ensure alignment: use each peer's FY2025 figures or clear TTM substitutes if a FY2025 restatement/delay exists; disclose any mismatches.
- Normalize NOPAT for cyclical firms by showing a 3-year average NOPAT alongside FY2025; present both FY2025 EV/NOPAT and cycle-adjusted EV/NOPAT.
- Adjust peers consistently for leases, pension deficits, or capitalized R&D so comparisons are apples-to-apples.
Presentation and analysis:
- Deliver a benchmark table and a chart (boxplot or bar chart) showing median, 25th/75th percentiles, and outliers for EV/NOPAT.
- Include complementary metrics: EV/EBITDA, ROIC (return on invested capital), FY2025 revenue growth, and margin to explain EV/NOPAT differentials.
- Flag peers where adjustments materially change ranking and provide sensitivity scenarios in the appendix.
One-liner: produce a peer benchmark of 3-5 matched companies using FY2025-aligned EV and NOPAT, plus adjustment notes.
Next steps and owners: Strategy selects the proposed peer list within 2 business days; Finance runs the benchmark and publishes results within 7 business days after peer approval.
![]()
All DCF Excel Templates
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.